Skip to content

Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects

Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04724304
Enrollment
115
Registered
2021-01-26
Start date
2021-02-09
Completion date
2021-11-11
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Brief summary

This study is being done to find out the normal amount of blood within the heart muscle and the variations in this blood flow between a cardiac MRI and TTE.

Interventions

DIAGNOSTIC_TESTReal-Time Myocardial Echocardiography (RTMPE)

Uses sound waves (ultrasound) to produce an images of the heart. During RTMPE a microbubble contrast agent is administered through an intravenous line (IV) to make the images of your heart clearer.

Imaging that focuses on the heart or blood vessels to assess size and function of the heart's chambers, thickness and movement of the walls of the heart, and blood flow in the blood vessels.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years. * Available for testing performed in Rochester, MN. * Willing to undergo both an echocardiogram with RTMPE and CMR. * Study subject providing consent.

Exclusion criteria

* Adults \< 18 years. * BMI \<30 kg/m\^2. * Hypertension. * Diabetes Mellitus. * Stroke. * Cardiomyopathy or structural heart disease. * Known coronary artery disease or history of myocardial infarction. * Contraindication to echo enhancement agent or gadolinium administration such as an allergy. * Renal GFR \< 50 mL/mL. * Females who are pregnant. * Subject unwilling to consent.

Design outcomes

Primary

MeasureTime frameDescription
Myocardial blood volumeBaselineRatio in systole and diastole (MBVs/MBVd) by real-time myocardial perfusion echocardiography (RTMPE)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026